UBS Reiterates Sell Rating on Ionis Pharmaceuticals (IONS) Ahead of PKK-LRx Phase 2 Topline
Go back to UBS Reiterates Sell Rating on Ionis Pharmaceuticals (IONS) Ahead of PKK-LRx Phase 2 Topline(NASDAQ: IONS) | Delayed: 41.84 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $41.84 | 52 Week High | $62.68 | |||
Open | $41.84 | 52 Week Low | $19.59 | |||
Day High | $41.84 | P/E | N/A | |||
Day Low | $41.84 | EPS | $0.00 | |||
Volume | 207 |